Novo Nordisk: Initiating Buy, Calling The Bottom
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-07-27T01:06:05.000Z","dateModified":"2026-07-27T01:07:44.000Z","description":"Novo Nordisk's oral Wegovy is expanding the treated obesity market, not just cannibalizing injectables. SeventyFour/iStock via Getty Images Investment Thesis and Company Overview I initiate coverage of Novo Nordisk (NVO) with a non-consensus BUY rating and a $68 price target.
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-07-27T01:06:05.000Z","dateModified":"2026-07-27T01:07:44.000Z","description":"Novo Nordisk's oral Wegovy is expanding the treated obesity market,
- ▪SeventyFour/iStock via Getty Images Investment Thesis and Company Overview I initiate coverage of Novo Nordisk (NVO) with a non-consensus BUY rating and a $68 price target.
Seeking Alpha files mainly under finance. We currently carry 6,549 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4925723-novo-nordisk-stock-initiating-buy-calling-the-bottom"},"author":{"@type":"Person","name":"Willow Tree…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
